CCR2 expression and Mo-AMs have been shown to drive bleomycin-induced pulmonary fibrosis, raising the possibility that CCR2+ monocytes drive pulmonary fibrotic disease through differentiation into Mo-AMs (23, 28). This evidence concerns the gene CCR2 and pulmonary fibrosis.